Allspring Global Investments’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.21M | Buy |
430,963
+120,631
| +39% | +$2.58M | 0.02% | 736 |
|
|
2025
Q1 | $5.06M | Buy |
310,332
+268,714
| +646% | +$4.39M | 0.01% | 915 |
|
|
2024
Q4 | $764K | Sell |
41,618
-80,007
| -66% | -$1.47M | ﹤0.01% | 1355 |
|
|
2024
Q3 | $1.87M | Buy |
121,625
+12,787
| +12% | +$197K | ﹤0.01% | 1174 |
|
|
2024
Q2 | $1.77M | Buy |
108,838
+49,992
| +85% | +$812K | ﹤0.01% | 1198 |
|
|
2024
Q1 | $1.09M | Sell |
58,846
-88,253
| -60% | -$1.63M | ﹤0.01% | 1345 |
|
|
2023
Q4 | $4.61M | Buy |
147,099
+22,008
| +18% | +$689K | 0.01% | 972 |
|
|
2023
Q3 | $2.61M | Buy |
125,091
+87,111
| +229% | +$1.82M | ﹤0.01% | 1121 |
|
|
2023
Q2 | $910K | Sell |
37,980
-51,029
| -57% | -$1.22M | ﹤0.01% | 1440 |
|
|
2023
Q1 | $1.68M | Buy |
89,009
+79,670
| +853% | +$1.5M | ﹤0.01% | 1294 |
|
|
2022
Q4 | $149K | Sell |
9,339
-2,513
| -21% | -$40K | ﹤0.01% | 1914 |
|
|
2022
Q3 | $193K | Buy |
11,852
+58
| +0.5% | +$944 | ﹤0.01% | 1830 |
|
|
2022
Q2 | $166K | Sell |
11,794
-50,466
| -81% | -$710K | ﹤0.01% | 1877 |
|
|
2022
Q1 | $1.51M | Buy |
62,260
+3,349
| +6% | +$81.1K | ﹤0.01% | 1653 |
|
|
2021
Q4 | $1.37M | Buy |
+58,911
| New | +$1.37M | ﹤0.01% | 1747 |
|